123 related articles for article (PubMed ID: 6862049)
1. Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice.
Capková J; Hasek M; Kousalová M; Holán V; Boubelík M
Folia Biol (Praha); 1983; 29(2):200-8. PubMed ID: 6862049
[TBL] [Abstract][Full Text] [Related]
2. Studies on the possibility of induction of anti-H-2 alloreactive cytotoxic antibodies by syngeneic immunization.
Opolski A; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1984; 32(5):621-30. PubMed ID: 6085470
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
5. [Production of heterologous antibodies to T-killers of mice immunized against H-2 antigens].
Egorova SG; Gritsman AIu; Brondz BD
Biull Eksp Biol Med; 1980 Jul; 89(7):62-4. PubMed ID: 6157432
[TBL] [Abstract][Full Text] [Related]
6. Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. I. Changes in reactivity with cytotoxic T lymphocytes and anti-H-2d sera.
Celis E; Hale AH; Russell JH; Eisen HN
J Immunol; 1979 Mar; 122(3):954-8. PubMed ID: 312828
[TBL] [Abstract][Full Text] [Related]
7. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.
Garrido F; Perez M; Torres MD; Garcia-Olivares E; Ivanyi P; Schirrmacher V
Immunobiology; 1979 Aug; 156(1-2):110-20. PubMed ID: 540966
[TBL] [Abstract][Full Text] [Related]
8. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
McKisic MD; Lancki DW; Fitch FW
J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
[TBL] [Abstract][Full Text] [Related]
9. [Selective inactivation of specific T-suppressors immune to H-2 complex antigens and prevention of their generation in vivo by antisuppressor xenogenic antibodies].
Abronina IF; Brondz BD; Suslov AP; Zaitseva MB; Karaulov AV
Mol Biol (Mosk); 1981; 15(5):1131-43. PubMed ID: 6457978
[TBL] [Abstract][Full Text] [Related]
10. Specificity of anti-H-2 class I antibodies induced by syngeneic immunization with Sendai virus-treated cells is regulated by the mouse MHC and viral antigens. No evidence for MHC-restricted virus-specific antibodies.
Kievits F; van Bleek GM; Boerenkamp WJ; Pla M; Ivanyi P
J Immunogenet; 1989 Feb; 16(1):3-17. PubMed ID: 2550555
[TBL] [Abstract][Full Text] [Related]
11. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
de Waal RM; Capel PJ; Koene RA
J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens.
Vlug A; Melief CJ; de Bruyne C; Schoenmakers H; Molenaar JL
J Natl Cancer Inst; 1980 May; 64(5):1191-8. PubMed ID: 6245302
[TBL] [Abstract][Full Text] [Related]
13. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
[TBL] [Abstract][Full Text] [Related]
14. Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells.
De Giorgi L; Matossian-Rogers A; Festenstein H
Immunology; 1979 Apr; 36(4):711-8. PubMed ID: 108205
[TBL] [Abstract][Full Text] [Related]
15. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
[TBL] [Abstract][Full Text] [Related]
16. Relationship between foreign H-2-like antigens on MCG4 sarcoma and the in vivo rejection of this tumor by syngeneic and semisyngeneic mice.
García-Olivares E; Torres MD; Gutiérrez F; Osorio C
Rev Esp Fisiol; 1982 Mar; 38(1):9-12. PubMed ID: 7100610
[TBL] [Abstract][Full Text] [Related]
17. [Specifics anti-tumor immunity induced by gene immunization with ectopic hCGbeta encoding gene].
Wang LX; Wu J; Guan QD; Xiong SD
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):316-9. PubMed ID: 12921555
[TBL] [Abstract][Full Text] [Related]
18. [Induction of T-cells--producers of macrophage migration inhibitory factors by mutant H-2 antigens in vivo].
Kharkevich DD; Suslov AP; Blandova ZK
Biull Eksp Biol Med; 1984 Apr; 97(4):443-5. PubMed ID: 6372888
[TBL] [Abstract][Full Text] [Related]
19. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells.
Hale AH; Ruebush MJ; Harris DT; McGee MP
J Immunol; 1981 Apr; 126(4):1485-8. PubMed ID: 6970778
[TBL] [Abstract][Full Text] [Related]
20. A new minor histocompatibility locus linked to H-3.
Click RE; Schneider D; Roopenian DC
J Immunol; 1981 Jun; 126(6):2378-81. PubMed ID: 7229381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
